Home » Topics » Regulatory

Regulatory
RSS

Emend approved for additional indication in Japan

June 25, 2012

ACE inhibitor approved in Japan to treat pediatric hypertension

June 22, 2012

Japanese authorities approve calcium channel blocker for pediatric hypertension

June 22, 2012

MSD obtains approval for Renivace in new indication

June 22, 2012

FDA approves MenHibrix

June 15, 2012

FDA approves Roche antibody for use in combination cancer therapy

June 11, 2012

FDA approves Horizant for new indication

June 8, 2012

AstraZeneca obtains approval for Inderal for new indication in Japan

May 25, 2012

Ocera obtains CE Mark for Zysa

May 21, 2012

First drug approved in E.U. for multiply relapsed/refractory aggressive NHL

May 11, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 18, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 18, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...